Lipegfilgrastim

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLipegfilgrastim
Drug Alias Name利培拉司亭GlycoPEGylated granulocyte colony-stimulating factor利培非格司亭GlycoPEG-GCSFLipegfilgrastimum +[10] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2013/07/25
Country/TerritoryCzechiaBulgariaUkraine +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Active CompaniesTeva Bv
Inactive CompaniesMerckle Gmbh
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA14
Related LinksKEGG